IPO registrations (S-1, F-1) · Registrants
NxStage Medical, Inc.
- SEC CIK
- 1333170 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2005-07-19, last 2006-06-08; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2005-10-28; declared effective 2006-06-08; withdrawal requested 2007-08-29
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 350 MERRIMACK STREET, Lawrence, MA 01843
- EIN
- 04-3454702
- EDGAR entity type
- operating
- Insiders and CEO pay
- NxStage Medical, Inc. on the corporate pages
Offering terms
- Proposed price range
- $11.00–$12.00 per share (S-1/A filed 2005-10-27)
- Final price
- $10.00 per share, below the range (424B4 filed 2005-10-28, an initial public offering)
- Shares sold
- 5,500,000
- Gross proceeds
- $55,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NXTM
- Lead underwriters
- Thomas Weisel Partners (1,025,000 shares); William Blair (768,750 shares); JMP Securities (512,500 shares)
- Syndicate
- First Albany Capital Inc (75,000); Leerink Partners (75,000); Pacific Growth Equities, LLC (75,000); Susquehanna Financial Group, LLLP (75,000); Wachovia (75,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: NxStage Medical, Inc. Fuzzy (name and state)
- Business registration: NXSTAGE MEDICAL, Inc. Fuzzy (name and state)
- Business registration: NXSTAGE MEDICAL INC Fuzzy (name and state)
- Business registration: NXSTAGE MEDICAL, INC. Fuzzy (name and state)
- Business registration: NXSTAGE MEDICAL, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: NXSTAGE MEDICAL, INC. EXACT (EIN (EXACT))
- Political committee (FEC): NXSTAGE MEDICAL INC POLITICAL ACTION COMMITTEE (connected to NXSTAGE MEDICAL INC) Fuzzy (name and state)
- Federal award recipient: NXSTAGE MEDICAL, INC. Fuzzy (name and state)
- Lobbying client: NXSTAGE MEDICAL Fuzzy (name and state)
- Lobbying client: NXSTAGE MEDICAL Fuzzy (name and state)
- Lobbying client: NXSTAGE MEDICAL Fuzzy (name and state)
- Lobbying client: NXSTAGE MEDICAL INC Fuzzy (name and state)
- Lobbying client: NXSTAGE MEDICAL INC Fuzzy (name and state)
- Lobbying client: NXSTAGE MEDICAL INC Fuzzy (name and state)
- SEC filer: NxStage Medical, Inc. EXACT (CIK (EXACT))
- Person page: Heyward R Donigan Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
- Person page: Robert G Funari Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-07-19 | S-1 | S-1 (registration) | NxStage Medical, Inc. | 0000950135-05-003988 ↗ |
| 2005-09-21 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-05-005483 ↗ |
| 2005-10-07 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-05-005697 ↗ |
| 2005-10-20 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-05-005833 ↗ |
| 2005-10-24 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-05-005899 ↗ |
| 2005-10-26 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-05-005957 ↗ |
| 2005-10-27 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-05-006012 ↗ |
| 2005-10-28 | 424B4 | 424B4 (final prospectus) | NxStage Medical, Inc. | 0000950135-05-006048 ↗ |
| 2006-05-17 | S-1 | S-1 (registration) | NxStage Medical, Inc. | 0000950135-06-003537 ↗ |
| 2006-05-26 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-06-003672 ↗ |
| 2006-06-08 | S-1/A | S-1/A (amendment) | NxStage Medical, Inc. | 0000950135-06-003842 ↗ |
| 2006-06-08 | EFFECT | EFFECT (declared effective) | NxStage Medical, Inc. | 9999999995-06-000234 ↗ |
| 2006-06-09 | 424B4 | 424B4 (final prospectus) | NxStage Medical, Inc. | 0000950135-06-003861 ↗ |
| 2007-05-08 | EFFECT | EFFECT (declared effective) | NxStage Medical, Inc. | 9999999995-07-001817 ↗ |
| 2007-08-29 | RW | RW (withdrawal request) | NxStage Medical, Inc. | 0000950135-07-005396 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-10-27 | S-1/A | registration statement | $11.00–$12.00 | $11.50 | 5,500,000 | $63,250,000 | Nasdaq NXTM | 2 | primary document; range, price sentence, shares headline, proceeds computed, underwriting table 2 | document ↗ |
| 2005-10-28 | 424B4 | final prospectus | $10.00 | 5,500,000 | $55,000,000 | Nasdaq NXTM | 8 | primary document; price sentence, shares headline, proceeds table, underwriting table 8 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Licari Philip R | Officer | SVP & Chief Operating Officer | 1 | 2006 | |
| GILL DAVID N | Officer | SVP & CFO | 1 | 2006 | |
| CHAMBON PHILIPPE | Director; Director,TenPercentOwner | 57 | 2006–2013 | ||
| CREDIT SUISSE/ | TenPercentOwner | 15 | 2006–2010 | ||
| ATLAS VENTURE ASSOCIATES III L P | TenPercentOwner | 1 | 2006 | ||
| ATLAS VENTURE ENTREPRENEURS FUND III L P | TenPercentOwner | 1 | 2006 | ||
| ATLAS VENTURE FUND III L P | TenPercentOwner | 1 | 2006 | ||
| FORMELA JEAN FRANCOIS | Director,TenPercentOwner | 1 | 2006 | ||
| Giannini Daniel A | Director | 43 | 2006–2019 | ||
| MOORE CRAIG W | Director | 47 | 2006–2019 | ||
| PHILDIUS PETER P | Director | 6 | 2006–2008 | ||
| REID PERPER | Director | 45 | 2006–2019 | ||
| Utterberg David S | Director; Director,TenPercentOwner | 63 | 2006–2013 | ||
| Burbank Jeffrey H | Director,Officer | CEO; Chief Executive Officer; President & CEO | 98 | 2006–2019 | |
| Brown Robert | Officer | President, Kidney Care; President, NxStage Kidney Care; Sr. Vice President, CFO | 65 | 2006–2017 | |
| Swan Winifred L | Officer | SVP and General Counsel | 121 | 2006–2019 | |
| Webb Michael J. | Officer | SVP Quality Assurance; SVP, Quality & Regulatory | 29 | 2007–2012 | |
| Azel Agustin | Officer | Senior VP, Manufacturing | 3 | 2007–2008 | |
| Turk Joseph E Jr | Officer | President; President, North America; SVP Commercial Operations | 159 | 2007–2019 | |
| Shea Thomas | Officer | SVP Manufacturing Operations | 46 | 2008–2013 | |
| ISALY SAMUEL D | Director; Director,TenPercentOwner; TenPercentOwner | 12 | 2008–2010 | ||
| ORBIMED ADVISORS LLC | Director; Director,TenPercentOwner; TenPercentOwner | 12 | 2008–2010 | ||
| SILVERSTEIN JONATHAN | Director,TenPercentOwner | 4 | 2008–2010 | ||
| LEWIS EARL R | Director | 29 | 2008–2019 | ||
| DEERFIELD CAPITAL LP | TenPercentOwner; TenPercentOwnerOther | 13 | 2009–2012 | ||
| DEERFIELD INTERNATIONAL LTD | TenPercentOwner; TenPercentOwnerOther | 10 | 2009 | ||
| DEERFIELD MANAGEMENT CO /NY | TenPercentOwner; TenPercentOwnerOther | 13 | 2009–2012 | ||
| DEERFIELD PARTNERS, LP | TenPercentOwner; TenPercentOwnerOther | 12 | 2009–2012 | ||
| DEERFIELD PRIVATE DESIGAN FUND L P | TenPercentOwner; TenPercentOwnerOther | 10 | 2009 | ||
| Deerfield Private Design International, L.P. | TenPercentOwner; TenPercentOwnerOther | 10 | 2009 | ||
| Deerfield Special Situations Fund International LTD | TenPercentOwner; TenPercentOwnerOther | 11 | 2009 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwner; TenPercentOwnerOther | 13 | 2009–2012 | ||
| Flynn James E | TenPercentOwner; TenPercentOwnerOther | 13 | 2009–2012 | person page Fuzzy | |
| HAM NANCY | Director | 4 | 2011–2012 | ||
| Miller Michael | Officer | President, International | 14 | 2011–2013 | |
| Straube Barry M | Director | 8 | 2011–2016 | ||
| Snell Todd M | Officer | SVP, QA, Reg.&Clinical Affairs | 7 | 2012–2013 | |
| Mixer Jean K | Director | 10 | 2012–2019 | ||
| Deerfield International Master Fund, L.P. | TenPercentOwnerOther | 1 | 2012 | ||
| Deerfield Special Situations International Master Fund, L.P. | TenPercentOwnerOther | 1 | 2012 | ||
| FUNARI ROBERT G | Director | 10 | 2013–2019 | person page Fuzzy | |
| Shreiner Jay W | Director | 3 | 2013–2014 | ||
| Hershberger Kevin | Officer | Chief Accounting Officer | 12 | 2013–2014 | |
| TOWSE MATTHEW W | Officer | Chief Financial Officer; SVP and Chief Financial Office | 31 | 2013–2019 | |
| Peters James J | Director | 4 | 2016–2019 | ||
| Donigan Heyward R | Director | 5 | 2016–2019 | person page Fuzzy |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | NxStage Medical, Inc. | MA | State business registries | name and state |
| Business registration | NXSTAGE MEDICAL, Inc. | MA | State business registries | name and state |
| Business registration | NXSTAGE MEDICAL INC | MA | State business registries | name and state |
| Business registration | NXSTAGE MEDICAL, INC. | MA | State business registries | name and state |
| Business registration | NXSTAGE MEDICAL, INC. | MA | State business registries | name and state |
| Contractor | NXSTAGE MEDICAL INC | MA | Nonprofit contractors (Form 990) | name and state |
| Plan sponsor | NXSTAGE MEDICAL, INC. | MA | Form 5500 (employee benefit plans) | name and state |
| Political committee | NXSTAGE MEDICAL INC POLITICAL ACTION COMMITTEE (connected to NXSTAGE MEDICAL INC) | MA | Campaign finance (FEC) | name and state |
| Federal award recipient | NXSTAGE MEDICAL, INC. | MA | Federal spending (USAspending) | name and state |
| Lobbying client | NXSTAGE MEDICAL | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | NXSTAGE MEDICAL | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | NXSTAGE MEDICAL | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | NXSTAGE MEDICAL INC | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | NXSTAGE MEDICAL INC | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | NXSTAGE MEDICAL INC | MA | Federal lobbying (LDA) | name and state |
| Paying company | NxStage Medical, Inc. | MA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | NxStage Medical, Inc. | MA | Patents (USPTO) | name and state |
| SEC filer | NxStage Medical, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | NxStage Medical, Inc. | MA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | NXSTAGE MEDICAL, INC. | EIN (EXACT) | ||
| Person page | Heyward R Donigan | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) | |
| Person page | Robert G Funari | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, MA first:
- VIKING SYSTEMS INC MA
- TransMedics, Inc. MA
- INFRAREDX INC MA
- Mevion Medical Systems, Inc. MA
- TransMedics Group, Inc. MA
- Candela Medical, Inc. MA
- CANDELA CORP /DE/ MA
- PRECISION OPTICS CORPORATION, INC. MA
- CYNOSURE INC MA
- ASPECT MEDICAL SYSTEMS INC MA
In other datasets, the same topic (Technology) in MA:
- Form D issuer: 10 Percent Happier, Inc. (Form D private offerings)
- Lobbying client: 5G ACTION NOW (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology